Monday, July 03, 2023 7:58:26 AM
There is, however, a good (illegal! but possibly lucrative) real use case for naked shorting, albeit sort of a strange and specialized one. It goes like this:
A publicly traded company is having some tough times and is looking to raise a bit of money. Ordinary financing options like a bond deal or a public stock offering are not available for whatever reason, so the company is looking for weird trades.
You arrange to buy some stock from the company, in the future, either at a fixed price or at some floating price indexed to the market price. So you sign a contract to buy 1 million shares two weeks from now at $1 per share (a fixed price), or to buy 1 million shares two weeks from now at the volume-weighted average price 3 of the stock over next two weeks (a floating price). You are giving the company money, and you are getting back stock, and because the company is a bit desperate you get a pretty good deal.
The stock is trading at, like, $1.25 today: You are getting a discount, buying at $1, because the company needs the money. (Or if you are buying at a floating price, it might be at a discount to the average market price.)
If you could sell 1 million shares at $1.25 today, then in two weeks you will buy them at $1, and you will make a $250,000 guaranteed profit. Whereas if you wait the two weeks, buy the shares at $1, and then sell them, maybe the stock will be below $1 by then and you will lose money. This company is risky! You want to lock in the profit now. (Similarly, but slightly more complicated, with a floating price: You want to sell the stock over the two-week period so you can get the average price, rather than waiting to buy at that price and then sell at whatever the price is in two weeks.)
But, look: If you have this sort of arrangement with this sort of troubled company, there is a good chance that it is hard to borrow 1 million shares. The company is small, its stock doesn’t trade that much, probably a lot of people have already borrowed it to short it. So you have to pay a large borrow fee, or more likely you simply cannot find 1 million shares to borrow at any price.
If you just naked shorted the stock, and sort of strung your brokers along for two weeks, you’d be fine: Sell at $1.25 today, buy at $1 in two weeks, and deliver the 1 million shares you bought to close out your short position. No harm done!
This is illegal in part because you are unfairly ducking the costs of short selling, but also because it is kind of a scammy way to do a stock offering: You are basically able to lock in a big profit by selling the stock to the company’s public shareholders before you buy it from the company, and it seems a bit unfair.
Recent GNS News
- Genius Group to Present at the Sidoti Micro Cap Conference • GlobeNewswire Inc. • 05/03/2024 02:30:00 PM
- Genius Group Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program • GlobeNewswire Inc. • 05/03/2024 02:00:00 PM
- Leading Education Entrepreneurs join Genius Group as New Shareholders • GlobeNewswire Inc. • 04/26/2024 12:00:00 PM
- Genius Group Appoints Alan Turing AI as Chief AI Officer • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
- Genius Group Appoints Leading Edtech Investor Michael Moe as Board Chairman • GlobeNewswire Inc. • 04/19/2024 04:00:00 PM
- Genius Group Launches Genius City Singapore: Company’s 1st Sovereign AI Education Ecosystem • GlobeNewswire Inc. • 04/12/2024 12:00:00 PM
- Genius Group launches AI Avatar Toolkit for Global Faculty to build their own AI Tutors • GlobeNewswire Inc. • 04/05/2024 12:00:00 PM
- Genius Group announces the appointment of Mr. Adrian Reese as Chief Financial Officer • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- Genius Group Updated 2024 Financial Guidance: $105 million to $110 million revenue with $6.0 million to $7.0 million positive EBITDA • GlobeNewswire Inc. • 03/21/2024 09:00:00 PM
- Genius Group and OpenExO Sign Merger Agreement, Accelerating Plans to Build Global AI Education Group • GlobeNewswire Inc. • 03/18/2024 05:00:00 PM
- Genius Group Release Additional Details of FatBrain AI Transaction • GlobeNewswire Inc. • 03/18/2024 11:00:00 AM
- Genius Group to Host Genius Investor Call on 21 March, 2024 Providing Revised Post-merger 2024 Guidance and Roadmap • GlobeNewswire Inc. • 03/15/2024 07:35:00 PM
- Genius Group Completes FatBrain AI Merger, 150% Increase in 2023 Combined Proforma Revenue Guidance • GlobeNewswire Inc. • 03/14/2024 06:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 01:00:18 PM
- Genius Group launches AI Avatar C-Suite, Featuring Einstein, Michelangelo & George Washington • GlobeNewswire Inc. • 03/07/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2024 09:30:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 03:54:49 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/27/2024 05:16:10 AM
- Genius Group expands AI-Powered Genius University • GlobeNewswire Inc. • 02/26/2024 12:00:00 PM
- Genus plc Reports Interim Results for the Six Months Ended 31 December 2023 • Business Wire • 02/22/2024 07:00:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/20/2024 10:11:20 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/14/2024 12:15:03 PM
- Genius Group launches AI Avatar Tutor Team on GeniusU • GlobeNewswire Inc. • 02/14/2024 12:00:00 PM
- Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow • GlobeNewswire Inc. • 01/24/2024 01:30:00 PM
- Genius Group 2024 Financial Guidance: 110% Growth to $56m - $60m Revenue with Positive EBITDA • GlobeNewswire Inc. • 01/22/2024 01:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM